Header Logo

Connection

Igor Koralnik to Humans

Back to Details
This is a "connection" page, showing publications Igor Koralnik has written about Humans.
Igor Koralnik
Connection Strength
3.085
Humans
  1. Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 10 17; 330(15):1491-1492.
    View in: PubMed
    Score: 0.050
  2. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection. Brain Behav Immun. 2023 Nov; 114:462-474.
    View in: PubMed
    Score: 0.049
  3. SARS-CoV-2-Specific Immune Responses in Patients With Postviral Syndrome After Suspected COVID-19. Neurol Neuroimmunol Neuroinflamm. 2023 11; 10(6).
    View in: PubMed
    Score: 0.049
  4. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein. Front Immunol. 2023; 14:1155770.
    View in: PubMed
    Score: 0.048
  5. Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity. Ann Neurol. 2023 07; 94(1):146-159.
    View in: PubMed
    Score: 0.048
  6. Evolution of neurologic symptoms in non-hospitalized COVID-19 "long haulers". Ann Clin Transl Neurol. 2022 07; 9(7):950-961.
    View in: PubMed
    Score: 0.045
  7. Global Teleneurology. Ann Neurol. 2022 04; 91(4):443-444.
    View in: PubMed
    Score: 0.045
  8. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection. Neurol Neuroimmunol Neuroinflamm. 2022 05; 9(3).
    View in: PubMed
    Score: 0.045
  9. LTA4H Prevalence and Mortality in Adult Zambians with Tuberculous Meningitis. Ann Neurol. 2021 12; 90(6):994-998.
    View in: PubMed
    Score: 0.043
  10. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021 05; 8(5):1073-1085.
    View in: PubMed
    Score: 0.042
  11. Reader Response: A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021 03 16; 96(11):550.
    View in: PubMed
    Score: 0.042
  12. Reply to COVID-19 encephalopathy, Bayes rule, and a plea for case-control studies. Ann Clin Transl Neurol. 2021 03; 8(3):726.
    View in: PubMed
    Score: 0.041
  13. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020 11; 7(11):2221-2230.
    View in: PubMed
    Score: 0.040
  14. COVID-19: A Global Threat to the Nervous System. Ann Neurol. 2020 07; 88(1):1-11.
    View in: PubMed
    Score: 0.040
  15. Children with Narcolepsy type 1 have increased T-cell responses to orexins. Ann Clin Transl Neurol. 2019 12; 6(12):2566-2572.
    View in: PubMed
    Score: 0.038
  16. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia. J Clin Microbiol. 2019 08; 57(8).
    View in: PubMed
    Score: 0.037
  17. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region. J Neurovirol. 2019 08; 25(4):475-479.
    View in: PubMed
    Score: 0.036
  18. JC virus infection of meningeal and choroid plexus cells in patients with progressive multifocal leukoencephalopathy. J Neurovirol. 2019 08; 25(4):520-524.
    View in: PubMed
    Score: 0.036
  19. Can Immune Checkpoint Inhibitors Keep JC Virus in Check? N Engl J Med. 2019 04 25; 380(17):1667-1668.
    View in: PubMed
    Score: 0.036
  20. ViroFind: A novel target-enrichment deep-sequencing platform reveals a complex JC virus population in the brain of PML patients. PLoS One. 2018; 13(1):e0186945.
    View in: PubMed
    Score: 0.033
  21. PML-IRIS in an HIV-2-infected patient presenting as Bell's palsy. J Neurovirol. 2017 10; 23(5):789-792.
    View in: PubMed
    Score: 0.032
  22. Developing a successful global neurology program. Ann Neurol. 2017 02; 81(2):167-170.
    View in: PubMed
    Score: 0.031
  23. Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy. J Neurovirol. 2016 08; 22(4):464-71.
    View in: PubMed
    Score: 0.029
  24. Brief Report: Role of Thymic Reconstitution in the Outcome of AIDS-Related PML. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):357-61.
    View in: PubMed
    Score: 0.029
  25. Simian Virus 40 Infection in the Spinal Cord of Simian Immunodeficiency Virus-Immunosuppressed Rhesus Macaques. J Neuropathol Exp Neurol. 2015 Nov; 74(11):1071-6.
    View in: PubMed
    Score: 0.029
  26. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathol Exp Neurol. 2015 Aug; 74(8):791-803.
    View in: PubMed
    Score: 0.028
  27. Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate. Ann Neurol. 2015 Oct; 78(4):501-14.
    View in: PubMed
    Score: 0.028
  28. JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression. J Virol Methods. 2015 Oct; 223:25-9.
    View in: PubMed
    Score: 0.028
  29. Novel syndromes associated with JC virus infection of neurons and meningeal cells: no longer a gray area. Curr Opin Neurol. 2015 Jun; 28(3):288-94.
    View in: PubMed
    Score: 0.028
  30. Training for a neurology career in a rare disease: The role of cyberconsults. Ann Neurol. 2015 May; 77(5):738-40.
    View in: PubMed
    Score: 0.028
  31. Finger pointing to JC virus: a tale of two indexes. Ann Neurol. 2014 Dec; 76(6):789-91.
    View in: PubMed
    Score: 0.027
  32. JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Neurology. 2014 Aug 19; 83(8):727-32.
    View in: PubMed
    Score: 0.026
  33. A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient. Ann Neurol. 2014 Jul; 76(1):140-7.
    View in: PubMed
    Score: 0.026
  34. JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34.
    View in: PubMed
    Score: 0.026
  35. Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy. Ann Neurol. 2014 May; 75(5):659-69.
    View in: PubMed
    Score: 0.026
  36. Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation. Biol Blood Marrow Transplant. 2014 Jul; 20(7):992-9.
    View in: PubMed
    Score: 0.026
  37. Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis. 2014 Jun; 58(12):1771-7.
    View in: PubMed
    Score: 0.026
  38. Agnogene deletion in a novel pathogenic JC virus isolate impairs VP1 expression and virion production. PLoS One. 2013; 8(11):e80840.
    View in: PubMed
    Score: 0.025
  39. Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study. J Neuropathol Exp Neurol. 2013 Nov; 72(11):1043-51.
    View in: PubMed
    Score: 0.025
  40. Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter. Ann Neurol. 2013 Oct; 74(4):503-5.
    View in: PubMed
    Score: 0.025
  41. Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome. Brain. 2013 Nov; 136(Pt 11):3441-50.
    View in: PubMed
    Score: 0.025
  42. ABO blood groups and risk for progressive multifocal leukoencephalopathy. JAMA Neurol. 2013 Oct; 70(10):1331-2.
    View in: PubMed
    Score: 0.025
  43. CSF viral escape in a patient with HIV-associated neurocognitive disorder. J Neurovirol. 2013 Aug; 19(4):402-5.
    View in: PubMed
    Score: 0.024
  44. Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis. Neuropathology. 2014 Feb; 34(1):39-44.
    View in: PubMed
    Score: 0.024
  45. Detection of JC virus-specific immune responses in a novel humanized mouse model. PLoS One. 2013; 8(5):e64313.
    View in: PubMed
    Score: 0.024
  46. A game of viral hide and seek: miliary PML masquerading as EBV encephalitis in an HIV+ patient. Clin Neurol Neurosurg. 2013 Sep; 115(9):1861-3.
    View in: PubMed
    Score: 0.024
  47. Comment: avoiding detrimental effects of corticosteroids on JC virus T-cell responses--primum non nocere. Neurology. 2012 Dec 04; 79(23):2263.
    View in: PubMed
    Score: 0.023
  48. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology. 2012 Nov 20; 79(21):2160; author reply 2160.
    View in: PubMed
    Score: 0.023
  49. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol. 2013 Jan 24; 8:189-215.
    View in: PubMed
    Score: 0.023
  50. Metabolic profile of PML lesions in patients with and without IRIS: an observational study. Neurology. 2012 Sep 04; 79(10):1041-8.
    View in: PubMed
    Score: 0.023
  51. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):244-8.
    View in: PubMed
    Score: 0.023
  52. JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. PLoS One. 2012; 7(4):e35793.
    View in: PubMed
    Score: 0.022
  53. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology. 2012 May 01; 78(18):1390-3.
    View in: PubMed
    Score: 0.022
  54. Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology. 2012 Jan 03; 78(1):73; author response 73-4.
    View in: PubMed
    Score: 0.022
  55. Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol. 2012 Jan; 71(1):54-65.
    View in: PubMed
    Score: 0.022
  56. JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol. 2012 Jan; 93(Pt 1):175-183.
    View in: PubMed
    Score: 0.022
  57. Hidden in plain view: emergence of progressive multifocal leukoencephalopathy after treatment of CNS toxoplasmosis. Acta Neurol Belg. 2011 Sep; 111(3):217-9.
    View in: PubMed
    Score: 0.021
  58. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis. 2011 Oct; 53(7):711-5.
    View in: PubMed
    Score: 0.021
  59. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol. 2011 Jul; 85(14):7256-63.
    View in: PubMed
    Score: 0.021
  60. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2010 Nov; 81(11):1288-91.
    View in: PubMed
    Score: 0.020
  61. JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. J Virol. 2010 Sep; 84(18):9200-9.
    View in: PubMed
    Score: 0.020
  62. Discrepant findings in immune responses to JC virus in patients receiving natalizumab. Lancet Neurol. 2010 Jun; 9(6):565-6; author reply 566-7.
    View in: PubMed
    Score: 0.020
  63. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010 Apr; 9(4):425-37.
    View in: PubMed
    Score: 0.019
  64. Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy. J Neurovirol. 2010 Feb; 16(1):41-7.
    View in: PubMed
    Score: 0.019
  65. The spectrum of neurological disorders in a Zambian tertiary care hospital. J Neurol Sci. 2010 Mar 15; 290(1-2):1-5.
    View in: PubMed
    Score: 0.019
  66. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009 Nov 10; 73(19):1551-8.
    View in: PubMed
    Score: 0.019
  67. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry. 2010 Mar; 81(3):247-54.
    View in: PubMed
    Score: 0.019
  68. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009 Sep 10; 361(11):1067-74.
    View in: PubMed
    Score: 0.019
  69. Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol. 2009 Jun; 65(6):742-8.
    View in: PubMed
    Score: 0.018
  70. Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis. 2009 Mar 15; 199(6):881-8.
    View in: PubMed
    Score: 0.018
  71. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol. 2009 Jan; 68(1):15-25.
    View in: PubMed
    Score: 0.018
  72. Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy. Virology. 2009 Jan 20; 383(2):173-7.
    View in: PubMed
    Score: 0.018
  73. Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol. 2008 Oct; 14(5):455-8.
    View in: PubMed
    Score: 0.018
  74. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol. 2008 Jun; 42(2):198-202.
    View in: PubMed
    Score: 0.017
  75. Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient. J Neurovirol. 2007 Oct; 13(5):474-6.
    View in: PubMed
    Score: 0.016
  76. Remission of progressive multifocal leukoencephalopathy and primary central nervous system lymphoma in an HIV-infected patient. Eur J Neurol. 2007 Jun; 14(6):598-602.
    View in: PubMed
    Score: 0.016
  77. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol. 2007 Apr; 81(7):3361-8.
    View in: PubMed
    Score: 0.016
  78. A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. J Gen Virol. 2006 Sep; 87(Pt 9):2533-2537.
    View in: PubMed
    Score: 0.015
  79. Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Ann Neurol. 2006 Aug; 60(2):162-73.
    View in: PubMed
    Score: 0.015
  80. JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients. J Neuroimmunol. 2006 Jul; 176(1-2):181-6.
    View in: PubMed
    Score: 0.015
  81. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol. 2006 Apr; 80(7):3495-505.
    View in: PubMed
    Score: 0.015
  82. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. J Neurovirol. 2006 Apr; 12(2):116-28.
    View in: PubMed
    Score: 0.015
  83. Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology. 2006 Jan 24; 66(2):262-4.
    View in: PubMed
    Score: 0.015
  84. Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies. AIDS. 2005 Dec 02; 19(18):2069-76.
    View in: PubMed
    Score: 0.014
  85. Progressive multifocal leukoencephalopathy as a complication of hepatitis C virus treatment in an HIV-negative patient. Clin Infect Dis. 2005 Aug 01; 41(3):417-9.
    View in: PubMed
    Score: 0.014
  86. Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med. 2005 Jul 28; 353(4):414-6.
    View in: PubMed
    Score: 0.014
  87. JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol. 2005 Apr; 57(4):576-80.
    View in: PubMed
    Score: 0.014
  88. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation. J Neurovirol. 2005 Feb; 11(1):46-50.
    View in: PubMed
    Score: 0.014
  89. New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab. J Neurovirol. 2005; 11 Suppl 3:52-7.
    View in: PubMed
    Score: 0.014
  90. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology. 2004 Sep 14; 63(5):897-900.
    View in: PubMed
    Score: 0.013
  91. Analysis of 15 novel full-length BK virus sequences from three individuals: evidence of a high intra-strain genetic diversity. J Gen Virol. 2004 Sep; 85(Pt 9):2651-2663.
    View in: PubMed
    Score: 0.013
  92. Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J Virol. 2004 Sep; 78(18):10206-10.
    View in: PubMed
    Score: 0.013
  93. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain. 2004 Sep; 127(Pt 9):1970-8.
    View in: PubMed
    Score: 0.013
  94. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol. 2004 Jun; 17(3):365-70.
    View in: PubMed
    Score: 0.013
  95. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med. 2004 Apr 29; 350(18):1882-93.
    View in: PubMed
    Score: 0.013
  96. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol. 2003 Nov; 77(22):11918-26.
    View in: PubMed
    Score: 0.012
  97. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition. J Neurol Sci. 2023 Nov 15; 454:120827.
    View in: PubMed
    Score: 0.012
  98. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology. 2003 Sep 23; 61(6):775-82.
    View in: PubMed
    Score: 0.012
  99. Pre-existing immunity modulates responses to mRNA boosters. Cell Rep. 2023 03 28; 42(3):112167.
    View in: PubMed
    Score: 0.012
  100. Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis. 2003 Feb; 24(2):301-6.
    View in: PubMed
    Score: 0.012
  101. Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol. 2003; 9 Suppl 1:25-31.
    View in: PubMed
    Score: 0.012
  102. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. J Neurovirol. 2002 Dec; 8 Suppl 2:59-65.
    View in: PubMed
    Score: 0.012
  103. The case of a 42-year-old man with progressive gait instability, dysarthria, and dysphagia. Ann Clin Transl Neurol. 2023 01; 10(1):144-145.
    View in: PubMed
    Score: 0.012
  104. Clinical presentation and outcomes of syphilitic meningitis among hospitalized adults in lusaka, Zambia. Int J STD AIDS. 2022 10; 33(12):1038-1044.
    View in: PubMed
    Score: 0.012
  105. Therapeutic Approaches to the Neurologic Manifestations of COVID-19. Neurotherapeutics. 2022 09; 19(5):1435-1466.
    View in: PubMed
    Score: 0.011
  106. Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patients. Geroscience. 2022 06; 44(3):1241-1254.
    View in: PubMed
    Score: 0.011
  107. Clinical characteristics and outcomes after new-onset seizure among Zambian children with HIV during the antiretroviral therapy era. Epilepsia Open. 2022 06; 7(2):315-324.
    View in: PubMed
    Score: 0.011
  108. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol. 2002 Jan 01; 168(1):499-504.
    View in: PubMed
    Score: 0.011
  109. Patient Income Does Not Predict Disability or Mortality in Hospitalized COVID-19 Patients in a Large Health Care System in the Chicago Metropolitan Area. J Health Care Poor Underserved. 2022; 33(3):1215-1229.
    View in: PubMed
    Score: 0.011
  110. Cross-protective immunity following coronavirus vaccination and coronavirus infection. J Clin Invest. 2021 12 15; 131(24).
    View in: PubMed
    Score: 0.011
  111. Teriflunomide Inhibits JCPyV Infection and Spread in Glial Cells and Choroid Plexus Epithelial Cells. Int J Mol Sci. 2021 Sep 10; 22(18).
    View in: PubMed
    Score: 0.011
  112. Advances in Treatment of Progressive Multifocal Leukoencephalopathy. Ann Neurol. 2021 12; 90(6):865-873.
    View in: PubMed
    Score: 0.011
  113. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol. 2001 Aug; 7(4):318-22.
    View in: PubMed
    Score: 0.011
  114. JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol. 2001 Jun; 75(12):5672-6.
    View in: PubMed
    Score: 0.011
  115. Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy. JAMA Neurol. 2021 06 01; 78(6):736-740.
    View in: PubMed
    Score: 0.011
  116. Acute-care hospital reencounters in COVID-19 patients. Geroscience. 2021 08; 43(4):2041-2053.
    View in: PubMed
    Score: 0.011
  117. A Dual-Platform Point-of-Care Test for Neurosyphilis Diagnosis. Sex Transm Dis. 2021 05 01; 48(5):353-356.
    View in: PubMed
    Score: 0.010
  118. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol. 2001 Apr; 75(7):3483-7.
    View in: PubMed
    Score: 0.010
  119. Diaphragm and Phrenic Nerve Ultrasound in COVID-19 Patients and Beyond: Imaging Technique, Findings, and Clinical Applications. J Ultrasound Med. 2022 Feb; 41(2):285-299.
    View in: PubMed
    Score: 0.010
  120. Abnormal movements in hospitalized COVID-19 patients: A case series. J Neurol Sci. 2021 04 15; 423:117377.
    View in: PubMed
    Score: 0.010
  121. Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol. 2001 Jan; 28(1):29-33.
    View in: PubMed
    Score: 0.010
  122. Transcranial Doppler Ultrasound Evidence of Active Cerebral Embolization in COVID-19. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105542.
    View in: PubMed
    Score: 0.010
  123. Clinicopathological characterization of an HIV-2-infected individual with two clonally unrelated primary lymphomas. Am J Hematol. 2000 Dec; 65(4):302-6.
    View in: PubMed
    Score: 0.010
  124. Brainstem progressive multifocal leukoencephalopathy. Eur J Neurol. 2021 03; 28(3):1016-1021.
    View in: PubMed
    Score: 0.010
  125. Imaging Review of Peripheral Nerve Injuries in Patients with COVID-19. Radiology. 2021 03; 298(3):E117-E130.
    View in: PubMed
    Score: 0.010
  126. Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications. J Neurol Neurosurg Psychiatry. 2021 02; 92(2):177-188.
    View in: PubMed
    Score: 0.010
  127. Evaluating the impact of antiretroviral and antiseizure medication interactions on treatment effectiveness among outpatient clinic attendees with HIV in Zambia. Epilepsia. 2020 12; 61(12):2705-2711.
    View in: PubMed
    Score: 0.010
  128. The World Health Organization's Essential Diagnostics List: Diagnostics for neurologic disorders. Neurology. 2019 10 08; 93(15):680-683.
    View in: PubMed
    Score: 0.009
  129. Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate. J Neurol. 2020 01; 267(1):125-131.
    View in: PubMed
    Score: 0.009
  130. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors. J Acquir Immune Defic Syndr. 2019 10 01; 82(2):220-224.
    View in: PubMed
    Score: 0.009
  131. Neurosyphilis. Semin Neurol. 2019 08; 39(4):448-455.
    View in: PubMed
    Score: 0.009
  132. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. J Neurovirol. 1999 Aug; 5(4):430-5.
    View in: PubMed
    Score: 0.009
  133. Olive Oil Intake Associated with Increased Attention Scores in Women Living with HIV: Findings from the Chicago Women's Interagency HIV Study. Nutrients. 2019 Jul 31; 11(8).
    View in: PubMed
    Score: 0.009
  134. Treatment of natalizumab-associated PML with filgrastim. Ann Clin Transl Neurol. 2019 May; 6(5):923-931.
    View in: PubMed
    Score: 0.009
  135. The neurobiological basis of narcolepsy. Nat Rev Neurosci. 2019 02; 20(2):83-93.
    View in: PubMed
    Score: 0.009
  136. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology. 1999 Jan 15; 52(2):253-60.
    View in: PubMed
    Score: 0.009
  137. Mortality & recurrent seizure risk after new-onset seizure in HIV-positive Zambian adults. BMC Neurol. 2018 Dec 07; 18(1):201.
    View in: PubMed
    Score: 0.009
  138. JC Virus Granule Cell Neuronopathy as AIDS-Presenting Illness. Can J Neurol Sci. 2018 07; 45(4):466-469.
    View in: PubMed
    Score: 0.009
  139. Neurologic illness in Zambia: A neurointensivist's experience. J Neurol Sci. 2018 02 15; 385:140-143.
    View in: PubMed
    Score: 0.008
  140. A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient. Transplantation. 2017 06; 101(6):1461-1467.
    View in: PubMed
    Score: 0.008
  141. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):246-255.
    View in: PubMed
    Score: 0.008
  142. New-onset seizure in HIV-infected adult Zambians: A search for causes and consequences. Neurology. 2017 01 31; 88(5):477-482.
    View in: PubMed
    Score: 0.008
  143. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. N Engl J Med. 2016 Nov 03; 375(18):1749-1755.
    View in: PubMed
    Score: 0.008
  144. JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. J Neurovirol. 2017 02; 23(1):141-146.
    View in: PubMed
    Score: 0.008
  145. Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals. J Neurovirol. 2016 08; 22(4):541-5.
    View in: PubMed
    Score: 0.007
  146. Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein. J Gen Virol. 1995 Aug; 76 ( Pt 8):1909-16.
    View in: PubMed
    Score: 0.007
  147. HIV and new onset seizures: slipping through the cracks in HIV care and treatment. HIV Med. 2016 Feb; 17(2):118-23.
    View in: PubMed
    Score: 0.007
  148. Acute EEG findings in HIV-infected Zambian adults with new-onset seizure. Neurology. 2015 Mar 31; 84(13):1317-22.
    View in: PubMed
    Score: 0.007
  149. BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation. Transpl Immunol. 2015 Mar; 32(2):116-20.
    View in: PubMed
    Score: 0.007
  150. Cognitive impairment and psychiatric morbidity in HIV+ Zambians with new-onset seizure. Am J Trop Med Hyg. 2014 Dec; 91(6):1254-8.
    View in: PubMed
    Score: 0.007
  151. JC polyomavirus granule cell neuronopathy in a patient treated with rituximab. JAMA Neurol. 2014 Apr; 71(4):487-9.
    View in: PubMed
    Score: 0.006
  152. Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review. Pediatr Infect Dis J. 2014 Apr; 33(4):e99-105.
    View in: PubMed
    Score: 0.006
  153. Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission. J Virol. 1994 Apr; 68(4):2693-707.
    View in: PubMed
    Score: 0.006
  154. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013 Apr 09; 80(15):1430-8.
    View in: PubMed
    Score: 0.006
  155. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol. 1993 Apr; 67(4):2360-6.
    View in: PubMed
    Score: 0.006
  156. EEG findings in asymptomatic HIV. Neurology. 1993 Mar; 43(3 Pt 1):635-6.
    View in: PubMed
    Score: 0.006
  157. Emerging subspecialties in neurology: global health. Neurology. 2013 Feb 19; 80(8):e78-80.
    View in: PubMed
    Score: 0.006
  158. In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I). AIDS Res Hum Retroviruses. 1992 Nov; 8(11):1845-9.
    View in: PubMed
    Score: 0.006
  159. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc Natl Acad Sci U S A. 1992 Sep 15; 89(18):8813-7.
    View in: PubMed
    Score: 0.006
  160. Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS. J Neurovirol. 2011 Oct; 17(5):500-3.
    View in: PubMed
    Score: 0.005
  161. Clinical Reasoning: An 83-year-old woman with progressive hemiataxia, tremor, and infratentorial lesions. Neurology. 2011 Jul 12; 77(2):e7-10.
    View in: PubMed
    Score: 0.005
  162. Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology. 2011 Jul 19; 77(3):297-9.
    View in: PubMed
    Score: 0.005
  163. [Neurological complication of human immunodeficiency virus infection]. Presse Med. 1991 Jun 22; 20(24):1129-35.
    View in: PubMed
    Score: 0.005
  164. Infrequent detection of KI, WU and MC polyomaviruses in immunosuppressed individuals with or without progressive multifocal leukoencephalopathy. PLoS One. 2011 Mar 16; 6(3):e16736.
    View in: PubMed
    Score: 0.005
  165. A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med. 1990 Sep 27; 323(13):864-70.
    View in: PubMed
    Score: 0.005
  166. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis. 2009 Oct; 9(10):625-36.
    View in: PubMed
    Score: 0.005
  167. Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia. J Clin Oncol. 2008 Aug 01; 26(22):3804-7.
    View in: PubMed
    Score: 0.004
  168. Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML). Int Immunol. 2007 Sep; 19(9):1083-93.
    View in: PubMed
    Score: 0.004
  169. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis. 2007 Sep 01; 196(5):709-11.
    View in: PubMed
    Score: 0.004
  170. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry. 2006 Sep; 77(9):1079-82.
    View in: PubMed
    Score: 0.004
  171. Polyomavirus nephropathy in kidney transplantation. Prog Transplant. 2004 Jun; 14(2):130-40; quiz 141-2.
    View in: PubMed
    Score: 0.003
  172. Basic and clinical research in polyomavirus nephropathy. Exp Clin Transplant. 2004 Jun; 2(1):162-73.
    View in: PubMed
    Score: 0.003
  173. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol. 2003; 9 Suppl 1:88-92.
    View in: PubMed
    Score: 0.003
  174. BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patient. Clin Infect Dis. 2002 Aug 01; 35(3):326-9.
    View in: PubMed
    Score: 0.003
  175. Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro Oncol. 2002 07; 4(3):165-70.
    View in: PubMed
    Score: 0.003
  176. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med. 2001 Oct 25; 345(17):1250-5.
    View in: PubMed
    Score: 0.003
  177. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology. 2001 Oct 09; 57(7):1313-6.
    View in: PubMed
    Score: 0.003
  178. [Effect of antiretroviral treatment on early electroencephalographic and otoneurologic manifestations in HIV infection and prognostic importance of verified perturbations]. Neurophysiol Clin. 1997 Dec; 27(6):508-19.
    View in: PubMed
    Score: 0.002
  179. Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines. Leukemia. 1997 Jun; 11(6):866-70.
    View in: PubMed
    Score: 0.002
  180. Mesencephalic clefts with associated eye movement disorders. Arch Ophthalmol. 1996 Apr; 114(4):429-32.
    View in: PubMed
    Score: 0.002
  181. Phylogenetic study of ten new HTLV-I strains from the Americas. AIDS Res Hum Retroviruses. 1994 Jan; 10(1):103-6.
    View in: PubMed
    Score: 0.002
  182. Neuro-otological manifestations in different stages of HIV infection. Acta Otolaryngol Suppl. 1991; 481:515-21.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.